Regeneron Pharmaceuticals (REGN)

Operating Expenses

$9.21B

TTM · Period ending: · USD

REGN logo

REGN Operating Expenses

Latest reported$9.21B
REGN TTM Operating Expenses (-$8.30M → $9.21B)
High-resolution chart · PNG

REGN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
9,212,500,000
8,984,700,000
8,664,300,000
8,478,100,000
8,322,300,000
8,253,700,000
8,240,800,000
7,761,700,000
7,321,500,000
6,957,800,000
6,600,300,000
6,437,800,000
6,130,000,000
5,675,200,000
5,272,200,000
4,935,100,000
4,712,200,000
4,559,900,000
4,401,199,999
3,987,399,999
3,815,799,999
3,750,599,999
3,564,700,000
3,635,400,000
3,454,600,000
3,557,600,000
3,372,400,000
3,510,341,000
3,674,304,000
3,470,535,000
3,594,033,000
3,447,681,000
3,355,714,000
3,276,940,000
3,250,108,000
3,122,962,000
3,109,419,000
3,179,630,000
3,173,253,000
3,153,174,000
3,003,838,000
2,716,788,000
2,459,103,000
2,198,427,000
2,049,986,000
1,881,983,000
1,776,108,000
1,630,845,000
1,465,021,000
1,328,032,000
1,189,362,000
1,077,900,000
961,426,000
896,578,000
836,309,000
762,936,000
718,598,000
691,254,000
646,767,000
627,230,000
604,091,000
575,562,000
554,235,000
544,203,000
524,776,000
491,434,000
453,778,000
407,762,000
374,711,000
348,890,000
327,364,000
313,823,000
289,578,000
262,335,000
239,478,000
206,616,000
186,465,000
174,363,000
162,956,000
-84,482,000
-77,974,000
-71,813,000
-67,785,000
175,893,000
165,570,000
159,244,000
153,157,000
151,019,000
152,258,000
148,931,000
150,809,000
151,125,000
149,979,000
146,432,000
137,458,000
132,470,000
122,865,000
111,186,000
101,147,000
88,503,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.